ZIOPHARM Oncology, Inc. ZIOP
0.87 +0.87
Day range unavailable
52-week range unavailable
Ownership
Held by insiders 9.93%
Held by institutions 56.28%
Float held by institutions 62.48%
Institutions 215
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 7.84% | 16,935,724 | 30.82M | Sep 29, 2021 |
| MSD Partners, L.P. | 7.01% | 15,151,516 | 27.58M | Sep 29, 2021 |
| Discovery Capital Management, LLC | 5.80% | 12,546,493 | 22.83M | Sep 29, 2021 |
| Vanguard Group, Inc. (The) | 5.73% | 12,385,833 | 22.54M | Sep 29, 2021 |
| State Street Corporation | 5.40% | 11,676,032 | 21.25M | Sep 29, 2021 |
| JP Morgan Chase & Company | 1.70% | 3,672,398 | 6.68M | Sep 29, 2021 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 3.36% | 7,254,095 | 10.08M | Nov 29, 2021 |
| Vanguard Total Stock Market Index Fund | 2.69% | 5,818,626 | 10.59M | Sep 29, 2021 |
| iShares Russell 2000 ETF | 2.26% | 4,888,689 | 7.33M | Oct 30, 2021 |
| Vanguard Extended Market Index Fund | 1.46% | 3,152,801 | 5.74M | Sep 29, 2021 |
| iShares Russell 2000 Growth ETF | 0.76% | 1,639,747 | 2.46M | Oct 30, 2021 |
| iShares NASDAQ Biotechnology ETF | 0.73% | 1,579,695 | 2.37M | Oct 30, 2021 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAFFA RAFFAELE | Officer | Stock Award(Grant) | May 16, 2021 | 280,645 |
| BOWDEN CHRISTOPHER J | Director | Stock Award(Grant) | Mar 3, 2021 | 4,167 |
| BOYLE KEVIN S. SR | Chief Executive Officer | Stock Award(Grant) | Aug 29, 2021 | 875,000 |
| BUCHI J. KEVIN CPA | Director | Stock Award(Grant) | Mar 3, 2021 | 4,167 |
| HADFIELD ROBERT | Officer | Stock Award(Grant) | Mar 3, 2021 | 176,819 |
| HAGEN HEIDI | Director | Purchase | Sep 1, 2021 | 145,889 |